Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

DA Davidson Downgrades Medifast to Neutral, Lowers Price Target to $106

DA Davidson analyst Linda Bolton Weiser downgrades Medifast (NYSE:MED) from Buy to Neutral and lowers the price target from $278 to $106.
byBenzinga Newsdesk
November 4, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

DA Davidson analyst Linda Bolton Weiser downgrades Medifast (NYSE:MED) from Buy to Neutral and lowers the price target from $278 to $106.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts